image
Healthcare - Biotechnology - NASDAQ - US
$ 1.43
-10.1 %
$ 87.8 M
Market Cap
-0.41
P/E
BALANCE SHEET
397 M ASSETS
-22.49%
92.9 M LIABILITIES
140.73%
304 M EQUITY
-35.79%
BALANCE SHEET DECOMPOSITION
Balance Sheet Pliant Therapeutics, Inc.
image
Current Assets 362 M
Cash & Short-Term Investments 356 M
Receivables 0
Other Current Assets 6.54 M
Non-Current Assets 34.7 M
Long-Term Investments 0
PP&E 32.8 M
Other Non-Current Assets 1.92 M
89.61 %8.25 %Total Assets$396.9m
Current Liabilities 33.2 M
Accounts Payable 5.96 M
Short-Term Debt 542 K
Other Current Liabilities 26.7 M
Non-Current Liabilities 59.6 M
Long-Term Debt 30.2 M
Other Non-Current Liabilities 29.4 M
6.42 %28.77 %32.53 %31.70 %Total Liabilities$92.9m

Balance Sheet

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017
ASSETS
Cash & Cash Equivalents 71.2 63.2 33.7 51.7 50.9 85.8 60.9 4.3
Short Term Investments 284.5 431.0 297.5 148.9 226.0 17.0 0 0
Receivables 0 3.0 2.0 2.0 9.4 7.4 0.5 0
Inventory 0 0 0 0 0 0 0 0
Other Current Assets 0.2 8.3 7.1 6.8 4.5 1.7 0.3 0.5
Total Current Assets 362.3 505.5 340.3 209.4 290.8 111.9 61.7 4.7
PP&E 32.8 4.8 9.9 10.9 4.3 4.1 4.3 1.8
Intangible Assets 0 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0 0
Long Term Investments 0 0 0 0 0 0 0 0
Other Long Term Assets 1.9 1.9 0.4 0.8 0.5 3.1 0.5 0
Other Assets 0 0 0 0 0 0 0 0
Total Assets 396.9 512.2 350.6 221.2 295.5 119.1 66.5 6.6
LIABILITIES
Accounts Payable 6.0 4.5 1.6 3.0 2.0 1.2 2.6 1.6
Short Term Debt 0.5 1.3 4.9 3.7 0 0 0 0
Other Current Liabilities 26.7 22.7 17.4 10.1 9.6 6.9 2.5 1.6
Total Current Liabilities 33.2 28.5 23.9 16.8 11.6 8.2 5.1 3.2
Long Term Debt 30.2 10.1 13.4 5.3 0 0.9 1.1 0
Deferred Tax Income 0 0 0 0 0 0 0 0
Other Liabilities 29.4 0 0 0 0.9 110.4 61.3 0
Total Liabilities 92.9 38.6 37.3 22.2 12.5 119.5 67.4 3.2
EQUITY
Common Stock 6 K 6 K 5 K 3 K 3 K 1 K 1 K 1 K
Retained Earnings (710.1) (499.7) (338.4) (215.1) (117.8) (76.3) (71.5) (36.6)
Other Accumulative Comprehensive Income/Loss 0 0.3 (2.0) (0.2) 32 K 1 K (1.1) 0
Total Equity 304.1 473.6 313.3 199.1 283.1 (0.4) (0.9) 3.3
Total Liabilities and Equity 396.9 512.2 350.6 221.2 295.5 119.1 66.5 6.5
SHARES OUTSTANDING
Common Shares Outstanding 60.5 58.7 42.0 35.8 35.6 35.6 16.5 0.8